ReviewRespiratory medicine2014
Idiopathic pulmonary fibrosis: early detection and referral.
Review in Respiratory medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.
- Effects of Exercise Training on Cardiopulmonary Function and Quality of Life in Elderly Patients with Pulmonary Fibrosis: A Meta-Analysis.International journal of environmental research and public health · 2021Pooled it
- Online multidisciplinary discussion on interstitial lung disease: Using new technologies to connect general hospitals to expert units.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2025Article
- Diagnosis of early idiopathic pulmonary fibrosis: current status and future perspective.Respiratory research · 2025Review
- Ectopic Expansion of Pulmonary Vasculature in Fibrotic Lung Disease and Lung Adenocarcinoma Marked by Proangiogenic COL15A1+ Endothelial Cells.Pulmonary circulation · 2025Article
- Quantitative CT analysis of idiopathic pulmonary fibrosis and correlation with lung function study.BMC pulmonary medicine · 2024Article
- Speaking of the "Devil": Diagnostic Errors in Interstitial Lung Diseases.Journal of personalized medicine · 2023Review
- Screening for idiopathic pulmonary fibrosis using comorbidity signatures in electronic health records.Nature medicine · 2022Article
- Potential interstitial lung abnormalities on chest X-rays prior to symptoms of idiopathic pulmonary fibrosis.BMC pulmonary medicine · 2022Article
- Diagnostic delay in IPF impacts progression-free survival, quality of life and hospitalisation rates.BMJ open respiratory research · 2022Observational
- Outcomes of Idiopathic Pulmonary Fibrosis Improve with Obesity: A Rural Appalachian Experience.Southern medical journal · 2021Observational
- Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis.Scientific reports · 2021Observational
- Aerobic and breathing exercises improve dyspnea, exercise capacity and quality of life in idiopathic pulmonary fibrosis patients: systematic review and meta-analysis.Journal of thoracic disease · 2020Review
- Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs.International journal of molecular sciences · 2020Review
- Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey.ERJ open research · 2019Article
- Risk factors for diagnostic delay in idiopathic pulmonary fibrosis.Respiratory research · 2019Article
- Association Between Pulmonary Vessel-Related Structures and Cryptogenic Fibrosing Alveolitis Using Derived Computed Tomography Among Chinese Patients.Medical science monitor : international medical journal of experimental and clinical research · 2019Article
- Potential Delays in Diagnosis of Idiopathic Pulmonary Fibrosis in Medicare Beneficiaries.Annals of the American Thoracic Society · 2019Article
- Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis.American journal of respiratory and critical care medicine · 2018Article
- Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey.BMC pulmonary medicine · 2018Article
- Are physicians in primary health care able to recognize pulmonary fibrosis?European clinical respiratory journal · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Idiopathic pulmonary fibrosis (IPF), a devastating progressive interstitial lung disease (ILD) with no known cause or cure, is the most common and deadly of the idiopathic interstitial pneumonias. With a median survival of 3-5 years following diagnosis, IPF is characterized by a progressive decline in lung function and quality of life in most patients. Vigilance among clinicians in recognizing IPF early in the disease course remains critical to properly caring for these patients, as this provides the widest range of management options. When IPF is suspected, a multidisciplinary evaluation (MDE) by a clinician, radiologist and pathologist with ILD expertise should occur, as this improves diagnostic agreement in both community and academic settings. When community MDE is not possible, or diagnostic doubt exists, referral to an ILD center should be considered. ILD center referral may also provide access specialized care, including clinical trials and lung transplantation, and should be considered for any patient with an established diagnosis of IPF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.